Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Titel:
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Auteur:
Monin, Leticia Laing, Adam G Muñoz-Ruiz, Miguel McKenzie, Duncan R del Molino del Barrio, Irene Alaguthurai, Thanussuyah Domingo-Vila, Clara Hayday, Thomas S Graham, Carl Seow, Jeffrey Abdul-Jawad, Sultan Kamdar, Shraddha Harvey-Jones, Elizabeth Graham, Rosalind Cooper, Jack Khan, Muhammad Vidler, Jennifer Kakkassery, Helen Sinha, Shubhankar Davis, Richard Dupont, Liane Francos Quijorna, Isaac O'Brien-Gore, Charlotte Lee, Puay Ling Eum, Josephine Conde Poole, Maria Joseph, Magdalene Davies, Daniel Wu, Yin Swampillai, Angela North, Bernard V Montes, Ana Harries, Mark Rigg, Anne Spicer, James Malim, Michael H Fields, Paul Patten, Piers Di Rosa, Francesca Papa, Sophie Tree, Timothy Doores, Katie J Hayday, Adrian C Irshad, Sheeba
Verschenen in:
Lancet oncology
Paginering:
Jaargang 22 () nr. 6 pagina's 765-778
Jaar:
2021
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license